... goals of the SPO, possible prospects and key points that investors should consider. Find out how Genetiko plans to use the funds for further growth and strengthening its position in the biotechnology market. Overview of the Additional Share Issue by Genetico: Goals and Prospects Genetico, a company specializing in genetic research and biotechnology, has announced a secondary public offering (SPO) at a price of 34 rubles per share. The decision for the additional issuance was made by the board of ...